JP2005532429A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005532429A5 JP2005532429A5 JP2004504726A JP2004504726A JP2005532429A5 JP 2005532429 A5 JP2005532429 A5 JP 2005532429A5 JP 2004504726 A JP2004504726 A JP 2004504726A JP 2004504726 A JP2004504726 A JP 2004504726A JP 2005532429 A5 JP2005532429 A5 JP 2005532429A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- group
- alkyl
- aryl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 35
- 150000001875 compounds Chemical class 0.000 claims 33
- 229910052739 hydrogen Inorganic materials 0.000 claims 23
- 125000003710 aryl alkyl group Chemical group 0.000 claims 21
- 125000003118 aryl group Chemical group 0.000 claims 15
- 239000001257 hydrogen Substances 0.000 claims 15
- 125000003107 substituted aryl group Chemical group 0.000 claims 15
- 125000006716 (C1-C6) heteroalkyl group Chemical group 0.000 claims 14
- 125000003545 alkoxy group Chemical group 0.000 claims 12
- 229920000642 polymer Chemical group 0.000 claims 12
- 150000002431 hydrogen Chemical group 0.000 claims 11
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 9
- 125000004405 heteroalkoxy group Chemical group 0.000 claims 9
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 9
- 125000000547 substituted alkyl group Chemical group 0.000 claims 9
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 9
- 229910052799 carbon Inorganic materials 0.000 claims 8
- 229910052760 oxygen Inorganic materials 0.000 claims 7
- 229910052717 sulfur Inorganic materials 0.000 claims 7
- 125000002877 alkyl aryl group Chemical group 0.000 claims 6
- 230000001588 bifunctional effect Effects 0.000 claims 6
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- 239000002202 Polyethylene glycol Substances 0.000 claims 4
- 125000000539 amino acid group Chemical group 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 4
- 125000003827 glycol group Chemical group 0.000 claims 4
- 125000004404 heteroalkyl group Chemical group 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 229920001223 polyethylene glycol Polymers 0.000 claims 4
- 108090000765 processed proteins & peptides Chemical group 0.000 claims 4
- 125000002431 aminoalkoxy group Chemical group 0.000 claims 3
- 125000004104 aryloxy group Chemical group 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 125000001475 halogen functional group Chemical group 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 3
- 229920006395 saturated elastomer Polymers 0.000 claims 3
- 125000006850 spacer group Chemical group 0.000 claims 3
- -1 NR 8 R 9 Chemical group 0.000 claims 2
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical class C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 claims 2
- 125000001188 haloalkyl group Chemical group 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 229920000233 poly(alkylene oxides) Polymers 0.000 claims 2
- 238000006116 polymerization reaction Methods 0.000 claims 2
- 125000006239 protecting group Chemical group 0.000 claims 2
- 229940123780 DNA topoisomerase I inhibitor Drugs 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 239000000365 Topoisomerase I Inhibitor Substances 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000012442 inert solvent Substances 0.000 claims 1
- 150000002596 lactones Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000007142 ring opening reaction Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/147,168 US6608076B1 (en) | 2002-05-16 | 2002-05-16 | Camptothecin derivatives and polymeric conjugates thereof |
| PCT/US2003/015526 WO2003097356A1 (en) | 2002-05-16 | 2003-05-16 | Camptothecin derivatives and polymeric conjugates thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005532429A JP2005532429A (ja) | 2005-10-27 |
| JP2005532429A5 true JP2005532429A5 (enExample) | 2006-05-11 |
Family
ID=27733658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004504726A Pending JP2005532429A (ja) | 2002-05-16 | 2003-05-16 | カンプトテシン誘導体およびそのポリマーコンジュゲート |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6608076B1 (enExample) |
| EP (1) | EP1503760A4 (enExample) |
| JP (1) | JP2005532429A (enExample) |
| AU (1) | AU2003232150A1 (enExample) |
| CA (1) | CA2485006A1 (enExample) |
| MX (1) | MXPA04011316A (enExample) |
| WO (1) | WO2003097356A1 (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6608076B1 (en) * | 2002-05-16 | 2003-08-19 | Enzon, Inc. | Camptothecin derivatives and polymeric conjugates thereof |
| US8394365B2 (en) | 2003-09-17 | 2013-03-12 | Nektar Therapeutics | Multi-arm polymer prodrugs |
| CN1852740B (zh) * | 2003-09-17 | 2011-05-11 | 耐科塔医药公司 | 多支链聚合物的药物前体 |
| EP1706399A1 (en) * | 2004-01-23 | 2006-10-04 | Elan Pharmaceuticals, Inc. | Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids |
| US8614228B2 (en) | 2004-08-11 | 2013-12-24 | Arqule, Inc. | Quinone prodrug compositions and methods of use |
| WO2006020719A2 (en) | 2004-08-11 | 2006-02-23 | Arqule, Inc. | Aminoacid conjugates of beta - lapachone for tumor targeting |
| US7612153B2 (en) * | 2004-10-25 | 2009-11-03 | Intezyne Technologies, Inc. | Heterobifunctional poly(ethylene glycol) and uses thereof |
| US7671067B2 (en) * | 2006-02-09 | 2010-03-02 | Enzon Pharmaceuticals, Inc. | Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamtothecin |
| US7462627B2 (en) * | 2006-02-09 | 2008-12-09 | Enzon Pharmaceuticals, Inc. | Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers |
| EP1998809B1 (en) | 2006-03-30 | 2014-06-25 | Drais Pharmaceuticals, Inc. | Camptothecin-cell penetrating peptide conjugates and pharmaceutical compositions containing the same |
| US7560588B2 (en) | 2006-04-27 | 2009-07-14 | Intezyne Technologies, Inc. | Poly(ethylene glycol) containing chemically disparate endgroups |
| MX2009005780A (es) | 2006-11-30 | 2009-06-10 | Nektar Therapeutics Al Corp | Metodo para preparar un conjugado de polimeros. |
| MX2009008549A (es) * | 2007-02-09 | 2009-08-18 | Enzon Pharmaceuticals Inc | Tratamiento de canceres resistentes o refractarios con conjugados polimericos de brazos multiples de 7-etil-10-hidroxicamptotecina. |
| BRPI0810717A2 (pt) * | 2007-04-30 | 2016-05-24 | Arqule Inc | sulfonato hidroxi de composto de quinona e seus usos |
| KR101671537B1 (ko) * | 2008-08-11 | 2016-11-01 | 넥타르 테라퓨틱스 | 다분지형 중합체 알카노에이트 컨쥬게이트 |
| TW201010732A (en) * | 2008-08-29 | 2010-03-16 | Enzon Pharmaceuticals Inc | Method of treating RAS associated cancer |
| MX2011003063A (es) | 2008-09-23 | 2011-04-21 | Nektar Therapeutics | Composiciones y metodos para lograr concentraciones terapeuticas de farmaco sostenidas en un individuo. |
| US20100098654A1 (en) * | 2008-10-21 | 2010-04-22 | Fabio Pastorino | Treatment of neuroblastoma with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
| CA2780645C (en) * | 2009-11-18 | 2018-01-16 | Nektar Therapeutics | Salt form of a multi-arm polymer-drug conjugate |
| US10894087B2 (en) | 2010-12-22 | 2021-01-19 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds |
| US20130331443A1 (en) | 2010-12-22 | 2013-12-12 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of taxane-based compounds |
| PL2797416T3 (pl) | 2011-12-28 | 2017-12-29 | Global Blood Therapeutics, Inc. | Podstawione związki benzaldehydowe i sposoby ich zastosowania do zwiększania natlenienia tkanek |
| US9012450B2 (en) | 2011-12-28 | 2015-04-21 | Global Blood Therapeutics, Inc. | Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation |
| EP2968299B1 (en) | 2013-03-15 | 2021-01-20 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9422279B2 (en) | 2013-03-15 | 2016-08-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| BR112015021982B1 (pt) | 2013-03-15 | 2022-12-13 | Global Blood Therapeutics, Inc | Compostos e seus usos para a modulação de hemoglobina |
| US8952171B2 (en) | 2013-03-15 | 2015-02-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9458139B2 (en) | 2013-03-15 | 2016-10-04 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| WO2014145040A1 (en) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation |
| US9604999B2 (en) | 2013-03-15 | 2017-03-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| JP6426694B2 (ja) | 2013-03-15 | 2018-11-21 | グローバル ブラッド セラピューティクス インコーポレイテッド | ヘモグロビンの修飾のための化合物及びその使用 |
| US9802900B2 (en) | 2013-03-15 | 2017-10-31 | Global Blood Therapeutics, Inc. | Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin |
| US20140274961A1 (en) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| EA201992707A1 (ru) | 2013-11-18 | 2020-06-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
| AP2016009261A0 (en) | 2014-02-07 | 2016-06-30 | Global Blood Therapeutics Inc | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
| MA41841A (fr) | 2015-03-30 | 2018-02-06 | Global Blood Therapeutics Inc | Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs |
| PL3383392T3 (pl) | 2015-12-04 | 2025-11-17 | Global Blood Therapeutics, Inc. | Schematy dawkowania dla 2-hydroksy-6-((2-(1-izopropylo-1H-pirazol-5-ilo)pirydyn3-ylo)metoksy)benzaldehydu |
| TWI663160B (zh) | 2016-05-12 | 2019-06-21 | 全球血液治療公司 | 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法 |
| TW202332423A (zh) | 2016-10-12 | 2023-08-16 | 美商全球血液治療公司 | 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑 |
| EP3860975B1 (en) | 2018-10-01 | 2023-10-18 | Global Blood Therapeutics, Inc. | Modulators of hemoglobin for the treatment of sickle cell disease |
| US12479816B2 (en) | 2019-02-08 | 2025-11-25 | University of Pittsburgh—of the Commonwealth System of Higher Education | 20-HETE formation inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1332413C (en) | 1987-06-25 | 1994-10-11 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives and process for preparing same |
| US5552154A (en) | 1989-11-06 | 1996-09-03 | The Stehlin Foundation For Cancer Research | Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof |
| JP4094710B2 (ja) | 1997-11-06 | 2008-06-04 | 株式会社ヤクルト本社 | 新規なカンプトテシン誘導体 |
| US6608076B1 (en) * | 2002-05-16 | 2003-08-19 | Enzon, Inc. | Camptothecin derivatives and polymeric conjugates thereof |
-
2002
- 2002-05-16 US US10/147,168 patent/US6608076B1/en not_active Expired - Fee Related
-
2003
- 2003-05-16 EP EP03753067A patent/EP1503760A4/en not_active Ceased
- 2003-05-16 CA CA002485006A patent/CA2485006A1/en not_active Abandoned
- 2003-05-16 WO PCT/US2003/015526 patent/WO2003097356A1/en not_active Ceased
- 2003-05-16 MX MXPA04011316A patent/MXPA04011316A/es active IP Right Grant
- 2003-05-16 JP JP2004504726A patent/JP2005532429A/ja active Pending
- 2003-05-16 AU AU2003232150A patent/AU2003232150A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU730244B2 (en) | High molecular weight polymer-based prodrugs | |
| US5965566A (en) | High molecular weight polymer-based prodrugs | |
| KR0148704B1 (ko) | 생체분해성 약물전달용 고분자 | |
| EP0596631A2 (en) | Novel polymeric antimicrobials and their use in pharmaceutical compositions | |
| JP5949037B2 (ja) | 末端に複数の水酸基を有するポリオキシエチレン誘導体 | |
| US20100184989A1 (en) | De Novo Synthesis of Conjugates | |
| US20120027859A1 (en) | Biodegradable Proline-Based Polymers | |
| EP1071455A4 (en) | FINALLY BRANCHED POLYMER LINKER MOLECULES AND POLYMER CONJUGATES CONTAINING THEM | |
| CA2780779A1 (en) | Acid salt forms of polymer-drug conjugates and alkoxylation methods | |
| JPH07309938A (ja) | 薬物送達マトリックス用の熱可塑性および生分解性ヒドロゲルマルチブロックコポリマー | |
| CA2497980A1 (en) | Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid | |
| WO2000075105A1 (en) | Valency platform molecules comprising aminooxy groups | |
| CA3094055A1 (en) | Branched monodispersed polyethylene glycol, intermediate and methods for producing same | |
| US20030202959A1 (en) | Polymeric acyl derivatives of indoles | |
| JP2005528380A5 (enExample) | ||
| AU2006283050A1 (en) | Methods of preparing polymers having terminal amine groups | |
| WO1999057174A1 (en) | Polyoxyethylene derivatives having optionally protected amino group at one end and process for producing the same | |
| AU2006302585A1 (en) | Methods of preparing polymers having terminal amine groups using protected amine salts | |
| KR20220069994A (ko) | 비대칭 분기형 분해성 폴리에틸렌글리콜 유도체 | |
| DE60018441T2 (de) | Blockcopolymer mit einem von oxazolin herrührenden segment | |
| CN107298673B (zh) | ε-己内酯衍生物及其制备方法和应用 | |
| JP2018172649A (ja) | 末端に複数の水酸基を有するポリオキシエチレン誘導体の製造方法 | |
| JP6925579B2 (ja) | 環状ベンジリデンアセタール構造を有する生分解性ヒドロゲル | |
| CN101248107A (zh) | 制备含有末端胺基的聚合物的方法 | |
| MXPA99001731A (en) | High molecular weight polymer-based prodrugs |